Subcuject is a innovative brand that offers a wearable injector platform for convenient and cost-effective self-administration of large and viscous doses. Their flagship product is the Subcutaneous Wearable Bolus Injection (WBI), which utilizes forward osmosis technology to generate force for injection of larger pharmaceutical volumes subcutaneously. Unlike traditional on-body injectors, the Subcuject WBI is simple, low cost, and patient-friendly.

It features invisible/automatic needle insertion and retraction, thin needles, small size and low weight, and operates noiselessly. The device is prefilled, preloaded, and single-use disposable, requiring no patient assembly or setting of device settings. It is also pharma company-friendly, with few moving parts, a manufacturing price comparable to prefilled autoinjectors, and no compromise on drug shelf life.

The Subcuject WBI can inject high viscosities and is designed for easy use with glass cartridge and standard rubbers as primary packaging. With pending patents covering core and peripheral functionality, Subcuject is revolutionizing the way large doses are administered, making it a reliable and efficient option for patients and pharmaceutical companies alike